Lexaria Bioscience Corp.

NASDAQ: LEXX · Real-Time Price · USD
0.80
0.00 (0.13%)
At close: Aug 15, 2025, 3:59 PM
0.82
2.44%
After-hours: Aug 15, 2025, 04:00 PM EDT

Lexaria Bioscience Revenue

Lexaria Bioscience reported an annual revenue of $464.28K, reflecting a 105.24% growth. For the quarter ending May 31, 2025, Lexaria Bioscience generated $174K in revenue.
Revenue (ttm)
464.28K
Revenue Growth
105.24%
Price / Sales Ratio
104.29
Revenue / Employee
66.33K
Employees
7
Market Cap
15.65M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Aug 31, 2024 464.28K +105.24%
Aug 31, 2023 226.21K -11.43%
Aug 31, 2022 255.4K -64.66%
Aug 31, 2021 722.74K +87.95%
Aug 31, 2020 384.54K +72.74%
Aug 31, 2019 222.61K -48.62%
Aug 31, 2018 433.29K +580.85%
Aug 31, 2017 63.64K +56.29%
Aug 31, 2016 40.72K +176.96%
Aug 31, 2015 14.7K -98.66%
Aug 31, 2014 1.1M -19.17%
Oct 31, 2012 1.36M +19.76%
Oct 31, 2011 1.13M +212.79%
Oct 31, 2010 362.47K -14.10%
Oct 31, 2009 421.95K -53.16%
Oct 31, 2008 900.79K +255.83%
Oct 31, 2007 253.15K +1146.60%
Oct 31, 2006 20.31K n/a
Oct 31, 2005 20.31K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.